Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Los medicamentos GLP-1 fueron desarrollados originalmente para tratar la diabetes tipo 2, pero su eficacia en la reduccin del peso llev a que organismos reguladores amplen su uso en pacientes con obesidad
This leads to lasting success
A consultation will determine if its right for you
However, these medications, classified as GLP-1 receptor agonists (for Semaglutide) and dual GLP-1/GIP receptor agonists (for Tirzepatide), are now being explored for a variety of other potential health benefits beyond their established uses including: improving cardiovascular health, exerting neuroprotective effects, exhibiting anti-inflammatory properties, ad potentially benefitting conditions such as polycystic ovary syndrome (PCOS) and chronic kidney disease
US$ 26.36
US$ 25.61
US$ 23.93
US$ 26.01
US$ 22.84
US$ 28.48
US$ 28.12
